Canada Is Now the World’s Largest Cannabis Market

OTTAWA – Supported by 3,420 licensed stores and roughly 7.1 million past-year consumers, Canada’s legal industry generated C$5.42 billion (approx. US$3.98 billion) in retail sales in 2025, making it the world’s largest federally-legal Cannabis market by a substantial margin.

That distinction matters. Unlike the United States, where Cannabis remains a Schedule I federal substance and legal sales exist only at the state level, every dollar of Canada’s $5-billion-plus market flows through a single nationally regulated framework.

Legalization is also delivering on its original public health premise. Research published in the International Journal of Drug Policy confirms “immediate” and “sustained” declines in illicit market activity since 2018. By 2025, approximately 76% of Canadian Сannabis spending flowed through licensed channels, up from just 24% at legalization. Quebec leads all provinces at 86%. British Columbia, with its deeply entrenched pre-legalization culture, remains lowest at 58%. Ontario, the country’s most populous province, accounts for roughly 40% of all national legal sales.

At the product level, 2025 brought a significant category shift. Analytics firm Headset confirms that pre-rolls overtook flower as Canada’s top-selling category [C$1.43 billion across 77.2 million units sold], marking the first time in the country’s legal market history that flower has not held the top revenue position.

The more striking story is Canada’s international reach. Medical Cannabis export volumes surpassed 275 tons in 2025, a 143% year-on-year increase and more than double the 2024 volume. Canada now accounts for an estimated 75% of the world’s legal medical Cannabis supply.

Germany, Europe’s fastest-growing patient market, absorbed the largest share. Canada-Germany shipments surged 298% in 2025, and Canada continued to supply 53% of Germany’s total medical imports in Q1 2026. The Global Cannabis Exchange projects Canadian exports to grow an additional 27% in 2026, with Germany and Australia continuing as primary destinations.

That dominance, however, faces real competitive pressure. Producers in Portugal, South Africa, and elsewhere are emerging as meaningful international suppliers, with growing unwillingness in Europe to accept Cannabis from Canada over EU-GMP-compliant supply grown locally. At home, domestic wholesale flower prices dropped to C$1.22 per gram in late 2025, a near two-year low driven by persistent oversupply.

Canada’s Cannabis market is entering a new phase; one where the domestic case for legalization has largely been made, and the global case is still being contested. Legal market share is rising, illicit activity is contracting, and product innovation continues to draw consumers deeper into regulated channels. Internationally, the picture is more competitive. Portugal and South Africa are no longer producers to observe from a distance. They’re now bidding for the same German import contracts that Canadian licensed producers built their export strategy around. EU-GMP compliance, pricing discipline, product differentiation, and diversified export routes will determine which Canadian operators sustain their global footprint as the international supply base matures and consolidates around its strongest players.